Garofalo Health Care H1 FY26 net profit drops 21.8% to €15.2 million; revenue rises 3.4% to €267 million

• Garofalo Health Care reported H1 2026 revenue of EUR 267 million, up 3.4% year on year.
• Group net profit fell 21.8% to EUR 15.2 million, while net financial position widened to EUR 219.3 million.
• Operating EBITDA adjusted rose 0.9% to EUR 47.6 million, holding the margin at 17.8%.
• Aurelia Group delivered EUR 61.8 million of revenue, including EUR 8.5 million from newly acquired Casa di Cura Città di Roma.
• CEO Maria Laura Garofalo cited a major investment plan targeting value creation from 2027, with M&A still in focus.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Garofalo Health Care S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 2142-21-2026_TELEBORSA.pdf), on September 10, 2026, and is solely responsible for the information contained therein.